Liven Pharma (KAR:LIVEN) LT-Debt-to-Total-Asset: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Liven Pharma LT-Debt-to-Total-Asset?

Liven Pharma KAR:LIVEN -5.04% LT-Debt-to-Total-Asset is 0.00 as of . 20. The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Liven Pharma's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Liven Pharma's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

Liven Pharma  (KAR:LIVEN) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Liven Pharma LT-Debt-to-Total-Asset Related Terms

Liven Pharma LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Liven Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liven Pharma LT-Debt-to-Total-Asset Chart

Liven Pharma Annual Data
Trend
LT-Debt-to-Total-Asset

Liven Pharma Semi-Annual Data
LT-Debt-to-Total-Asset

Liven Pharma LT-Debt-to-Total-Asset Calculation

Liven Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Liven Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Liven Pharma (KAR:LIVEN) has a LT-Debt-to-Total-Asset of 0.00 as of . 20. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Liven Pharma and its competitors.
Is Liven Pharma's LT-Debt-to-Total-Asset too high?
Liven Pharma's current LT-Debt-to-Total-Asset is 0.00.
How does Liven Pharma's LT-Debt-to-Total-Asset compare to AIN?
Liven Pharma's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Manufacturing - Apparel & Accessories company?
A good LT-Debt-to-Total-Asset depends on the Manufacturing - Apparel & Accessories industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Liven Pharma and its competitors. Liven Pharma's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liven Pharma stock overvalued right now?
Liven Pharma (KAR:LIVEN) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Liven Pharma (KAR:LIVEN), the current LT-Debt-to-Total-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Liven Pharma Business Description

Address I.I Chundrigar Road, 1st Floor, The Cotton Exchange Building, Karachi, SD, PAK, 75350
Liven Pharma Ltd, formerly Landmark Spinning Industries Ltd is engaged in trading, manufacturing, and sale of yarn.